drugset / Trial / NCT07451171

Summary

The purpose of this Phase IIa study is to identify the most effective antibiotic regimen to treat small intestine bacterial overgrowth (SIBO) in impoverished Bangladeshi children.

Timeline

Start
2026-04-18
Primary completion
2026-08-02
Completion
2026-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 20 mg/kg Oral
Subject Amoxicillin Other / unclassified 40 mg/kg Oral
Subject Metronidazole Small molecule 20 mg/kg Oral
Subject Metronidazole Small molecule 30 mg/kg Oral
Subject Metronidazole Small molecule 35 mg/kg Oral
Subject Metronidazole Small molecule 50 mg/kg Oral
Subject trimethoprim-sulfamethoxazole Unknown 8 mg/kg Oral
Subject trimethoprim-sulfamethoxazole Unknown 10 mg/kg Oral